MorphoSys (NASDAQ:MOR) Price Target Cut to €40.00

MorphoSys (NASDAQ:MOR – Get Rating) had its target price lowered by analysts at Morgan Stanley from €50.00 ($54.95) to €40.00 ($43.96) in a research note issued to investors on Monday, The Fly reports. The brokerage currently has an “equal weight” rating on the stock. A number of other research analysts have also commented on the […]

Related Keywords

United States , ,Morgan Stanley ,Berenberg Bank ,Zacks Investment Research ,Deutsche Bank Aktiengesellschaft ,Blackrock Inc ,Alphacentric Advisors ,Morphosys Company Profile Get Rating ,Millennium Management ,Citigroup ,Get Rating ,Bank Aktiengesellschaft ,Investment Research ,Bay Capital Management ,Sys Company Profile ,Morphosys ,Nasdaq Mor ,Humor ,Medical ,Lower Price Target ,